ARCHIVES

Low Dose DFMO Reduces Colon Adenoma Recurrence

This article is from The Cancer Letter archive.

Vol. 31 No. 4 | April 25, 2008

Download PDF Visit The Full Archive

Related Articles

FDA Discloses Avastin Regulatory History.

December 14, 2007

New: Special Reports on the Dialogue and NCI’s 2015 goal posted at cancerletter.com.

August 8, 2003

Women’s Health Study To Supplant Need for WHT, Greenwald Says

May 31, 1991

Senate Appropriations Committee Slashes NCI Funds By $25 Million

August 18, 1978

FDA Committee IK IL-2/LAK For Modified Group C

May 1, 1987

Karen Antman recruited to NCI on an IPA to oversee changes to centers, SPORE programs.

October 31, 2003